August 5, 2021

Volume XI, Number 217

Current Issues with COVID-19 Commercial Reimbursement

Polsinelli invites you to join us for a two part webinar series that will discuss commercial reimbursement issues affecting healthcare providers caring for patients with known or suspected exposure to COVID-19, new federal laws that apply to commercial reimbursement, unique questions that have arisen, and state regulatory guidance designed to assist providers. Our speakers will also cover health care provider opportunities to resolve claims backlog and to anticipate and plan for reimbursement and contracting in the post-COVID environment.

  • Reimbursement for diagnostic and antibody testing
  • Attempted “cram-down” amendments
  • Capitated v. non-capitated situations
  • Force majeure contract provisions and considerations
  • Insurer waivers of certain requirements
  • Navigating patient loss of coverage/eligibility
  • Special insurer funding programs for providers
  • Ideas for regulatory/legislative support based on the New York experience